Introduction
============

COPD is a large, growing public health problem. According to the World Health Organization, its expected burden will increase in the coming decades, mostly due to continued exposure to risk factors, population growth and aging, to become the third leading cause of death by 2030.[@b1-copd-13-057]

Despite being a major health problem, existing data on COPD prevalence are limited in many countries, and universally high COPD underdiagnosis[@b2-copd-13-057] or misdiagnosis[@b3-copd-13-057] deprives patients and health authorities of the implementation of adequate preventive and therapeutic measures, in order to avoid its potential serious effects and high costs.[@b4-copd-13-057] In fact, of the 50 sovereign European countries, only 19 (38%) of them have available reliable data on COPD prevalence.[@b5-copd-13-057]

The geographic information system (GIS) is considered a useful tool for reporting the distribution of health-related states, in particular diseases.[@b6-copd-13-057],[@b7-copd-13-057] Specifically, the GIS inverse distance weighting (IDW) interpolation (or spatial analysis) technique (an informatics mathematical approach of manipulating spatial information to extract new information and meaning from the original data, using points with known values to estimate values at other unknown points) has proved to be an effective tool in spatial distribution estimation of epidemiological variables, when real data are few and widely separated, as might be the case with the COPD prevalence in Europe.[@b8-copd-13-057]--[@b10-copd-13-057]

The objective of the present study was to apply the IDW mapping to integrate the existing data from different European areas, in order to represent cartographically the mean percentage of the population affected by COPD in each geographical region of the entire continent, both in studied areas with known data and in many other areas in which no studies have been conducted and consequently with blank data.

Methods
=======

Source of epidemiological studies for COPD prevalence
-----------------------------------------------------

The vast majority of the data entered in the database used in the IDW interpolation software were taken from the systematic review and meta-analysis recently published by Adeloye et al on the prevalence of COPD across the world from January 1990 to December 2014, based on a confirmed diagnosis of COPD with different formally acknowledged spirometric criteria.[@b5-copd-13-057] For the current study, only the variables referring to the place of origin of the samples and the mean COPD prevalence (in percent) of the samples composed of subjects aged ≥40 years were used.[@b11-copd-13-057]--[@b63-copd-13-057] To the initially selected 61 studies, a later one on the prevalence of COPD, as defined by the Global Initiative for Obstructive Lung Disease (GOLD), in a representative sample of northeastern Italy general population was added.[@b64-copd-13-057]

The application of an age selection criterion of ≥40 years excluded, from the present study, an international study that included young subjects from several cities in Europe aged between 20 and 44 years,[@b65-copd-13-057] 2 studies performed in 12 Russian regions,[@b66-copd-13-057],[@b67-copd-13-057] and another study of the Turkish region of Elazig all of them carried out in subjects from the age of 18.[@b68-copd-13-057]

In addition, to facilitate visual comparisons between Europe and the neighboring regions of Asia and Africa, the available COPD prevalence data from several Middle East and North Africa regions were also included.[@b69-copd-13-057]--[@b77-copd-13-057]

IDW multivariate interpolation method
-------------------------------------

To elaborate colored geographical maps of COPD prevalence, an IDW interpolation process was started through the freely available software QGIS 18.9 in order to link it with the 7.3 64-bit wxPython 3 Geographic Resources Analysis Support System (GRASS).

Then, the geographical longitude and latitude coordinates of the different places were automatically obtained for each point by translating the location of the place of origin of the samples included. The translation was made through the Google Maps application programming interface using the web page of GPS Visualizer (Carleton University Library, Ottawa, ON, Canada).

Then, these geographical coordinates were imported into the database and then exported to a "csv" (comma separated value) text file, which was opened and visualized in QGIS. A shape file containing the contours of all world countries was also loaded.

Finally, the interpolation process was carried out by applying the "v.surf.idw" library included in the GRASS GIS version 7, another free and open source GIS software suite used for geospatial data management and analysis, spatial modeling, image processing, graphics and maps production, and visualization.

The v.surf.idw library provided surface interpolation from vector point data by filling out a raster matrix with interpolated values generated from a set of irregularly spaced data points, using numerical approximation (weighted averaging) techniques. The interpolated value of a cell was determined by the values of the nearby data points and the distance of the cell from those input points.

An implementation of an IDW technique, as defined by Shepard,[@b7-copd-13-057] is as follows: the way to find an interpolated value u at a given (arbitrary) point x based on N known samples u~i~=u(x~i~) for i=1, 2, ..., N is: $$\begin{array}{l}
{u(x) = \begin{cases}
\frac{\sum_{i = 1}^{N}{w_{i}(x)u_{i}}}{\sum_{i = 1}^{N}{w_{i}(x)}} & {\text{if~d}(x,x_{i}) \neq 0\ \text{for~all~i}} \\
u_{i} & {\text{if~d}(x,x_{i}) = 0\ \text{for~some~i}} \\
\end{cases}} \\
{\quad\text{where~w}_{i}(x) = \frac{1}{d\left( x,x_{i} \right)^{p}}} \\
\end{array}$$

The "N known samples" is the N closest ones to the interpolation point. In our study, the usual N value of 4 (N=4) was chosen. This means that a sample point takes the 4 closest pixel centers and linearly interpolates their color values according to their distance from the sample point; p is called the power parameter, which has a default value of 2, which was the value used in this study.

To express the range of values in the maps, a progressive gradient (low--high) range scale of 10 colors, creating a diverging low--mid--high color gradient, with dark blue tones representing the lowest values, yellow and green representing the intermediate ones, and brown and dark red representing the highest ones, was used.

Geographical regions of Europe
------------------------------

Although there is not a universally accepted definition of the boundaries and countries of the European regions, to facilitate the description of findings, we used a simple and conventional classification of the regions of Europe into 5 major subregions, namely Northern Europe, Western Europe, Central Europe, Southern Europe, and Eastern Europe.[@b79-copd-13-057]

Northern Europe consists approximately of the Europe regions above the 52nd parallel north, and in this geographical area, the following countries have been included for this study: Iceland, Denmark, Norway, Sweden, Finland, Estonia, Latvia, and Lithuania.

In Western Europe, the following countries have been included: the Netherlands, Belgium, Luxembourg, France, Ireland, and UK.

In Central Europe, the following countries have been included: Germany, Austria, Poland, Slovakia, Czech Republic, Hungary, Slovenia, and Switzerland.

In Southern Europe, the following countries have been included: Spain, Portugal, Italy, Greece, Malta, Cyprus, and Turkey.

Although there is no consensus on the precise area covered by Eastern Europe, because the term has a wide range of geopolitical, geographical, cultural, and socioeconomic connotations, the following countries have been included in this region: the Balkan Peninsula countries (Albania, Croatia, Bosnia and Herzegovina, Montenegro, Serbia, and Macedonia), Romania, Moldova, Bulgaria, Ukraine, Belarus, and European Russia.

Statistical analysis
--------------------

Descriptive statistics were used to summarize study sites. Quantitative variables were expressed as mean and SD, 95% CI for the mean, and range, and they were analyzed using the analysis of variance. A *p*\<0.05 was considered statistically significant. Statistical calculations were performed using the analytical software SPSS 19 (IBM Corp., Armonk, NY, USA).

Results
=======

The cohorts
-----------

A total of 62 studies from 19 countries (21 from 5 Northern European countries, 11 from 3 Western European countries, 14 from 5 Central European countries, and 16 from 6 Southern European countries) were selected ([Tables 1](#t1-copd-13-057){ref-type="table"}[](#t2-copd-13-057){ref-type="table"}[](#t3-copd-13-057){ref-type="table"}--[4](#t4-copd-13-057){ref-type="table"}). As mentioned previously, no prevalence data were available for any of the 12 countries from Eastern Europe.

Numbers of point estimates by individual countries (from high to less) were as follows: Sweden, 8; United Kingdom, 7; Norway, 5; Finland, Germany, and Turkey, 4 each; the Netherlands, Austria, Poland, Portugal, and Spain, 3 each; Italy and Greece, 2; and other remaining countries, 1.

Accordingly, a total of 329,413 subjects from the 4 regions of Europe with published data were studied; they were distributed as follows: 39,836 in Northern Europe; 229,083 in Western Europe; 25,553 in Central Europe; and 34,941 in Southern Europe.

The size of the selected samples was significantly different in the 4 European regions, with a mean (minimum and maximal values in parentheses) of 1,897 (548--6,525) subjects in Northern Europe; 20,751 (246--185,325) in Western Europe; 1,825 (432--6,126) in Central Europe; and 2,329 (500--9,061) in Southern Europe.

Most of the studies were conducted in isolated cities or localized regions of a particular country, while only a few were carried out on samples representative of the adult general population of an entire country, such as those performed in the Netherlands,[@b33-copd-13-057] UK,[@b39-copd-13-057] Switzerland,[@b50-copd-13-057] Portugal,[@b52-copd-13-057] Spain,[@b54-copd-13-057],[@b55-copd-13-057] and Cyprus.[@b60-copd-13-057]

According to the study base of the samples, 23 of them were classified as urban (7 from Northern Europe, 4 from Western Europe, 7 from Central Europe, and 5 from Southern Europe), 9 (6 from Northern Europe, 1 from Central Europe, and 2 from Southern Europe) were classified as rural, and the remaining 30 were catalogued as mixed.

The mean age of the subjects from the 62 selected samples was 55.9 years (SD =6.1), without significant differences between regions ([Table 5](#t5-copd-13-057){ref-type="table"}).

In 80% of the studies, the diagnosis of COPD was made by using the GOLD spirometric criteria of the postbronchodilator (post-BD) fixed ratio FEV~1~/FVC \<0.70; in the remaining 12 studies, other spirometric criteria (not post-BD) endorsed by different scientific societies were used, such as the lower limit of normal, the British Thoracic Society, the American Thoracic Society, and European Respiratory Society criteria.

COPD prevalence
---------------

The global mean prevalence of COPD (expressed in percent) was 12.38 (SD =6.2) without significant differences among the 4 European regions with available data ([Table 6](#t6-copd-13-057){ref-type="table"}).

The highest values of prevalence were found in 2 samples from the cities of Manchester and Salzburg (26% each), followed by those of Ashington and Copenhagen (with 25% each); the COPD subjects from Glasgow, the Po Delta area of Italy, and the southern Poland region of Malopolska (with 24%, 23%, and 22%, respectively); and the COPD subjects from the metropolitan areas of Stockholm and Vienna (with 20% each).

Prevalence rates between ≥15% and ≤20% were found in the cities of Bergen and Maastricht and in the Turkish province of Adana (all with 19%), in the metropolitan areas of Reykjavik and Thessaly (both 18%), and in Berlin (with 16%).

Prevalence ranges between ≥10% and ≤15% were found in a sample from Luleå (in the northernmost county of Sweden) with 14%, followed by 2 samples from Barton-upon-Humber (England) and Hannover (Germany) both with 13% and the patients' samples from the Danish cities of Aarhus and Aalborg and the Dutch city of Rotterdam (with 12%). Prevalence value of 11% was found in Warsaw, in the Polish region of Lublin, and in the Swedish counties of Norrbotten and Örebro. Prevalence values slightly \>10% were found in Slovenia, Spain, and Portugal and in the general population of the UK.

In practically all of the remaining places with available data, prevalence ranged from 5 to \<10%. Anecdotally, a young rural cohort, with a mean age of 45 years, from the Swedish county of Värmland showed the lowest prevalence of COPD in Europe, with a percentage slightly \>2%.

IDW interpolation maps
----------------------

In the IDW interpolation map of [Figure 1](#f1-copd-13-057){ref-type="fig"}, the prevalence rates of COPD of all European countries are represented by a red--blue scale. Black spots indicate the places of origin of the samples.

In a simplified way, since there is no exact equivalence between the qualitative data provided by the color scale and the quantitative ones provided by the numerical values, it can be interpreted with reasonable certainty that red tones represent the maximum values \>20%; brown and orange colors symbolize high but lower values of \~15%--20%; shades of yellow and green tones represent intermediate values of \~10%--15%; and blue tones represent minimal values of 0%--5%.

The greatest numbers of black spots are located in the Iberian Peninsula, Great Britain, Central Europe, and the coastal regions bordering the North and the Baltic Seas. In contrast, spots are in general scattered and scanty in most of the remaining parts of the continent and absolutely absent in the Mediterranean islands of Corsica, Sardinia, Sicily and Greek islands, southern Italy, Balkan Peninsula, and regions belonging to Eastern Europe.

Some black spots can also be seen in some nearby countries of North Africa and Middle East (for guidance).

In [Figure 2](#f2-copd-13-057){ref-type="fig"}, the numerical values of the corresponding prevalence rates have been added. The numerical values appear with a decimal and are the same reproduced (rounded) in [Tables 1](#t1-copd-13-057){ref-type="table"}[](#t2-copd-13-057){ref-type="table"}[](#t3-copd-13-057){ref-type="table"}--[4](#t4-copd-13-057){ref-type="table"}.

In the map of [Figure 3](#f3-copd-13-057){ref-type="fig"}, both black spots and numerical figures have been removed to allow a clearer view of the colors with which the different regions were colored.

A very high prevalence represented by red tones (≈20%--27%) appears in practically all Great Britain, except in the south of the island that presents brownish colors in the west and yellow in the center and east consistent with an intermediate prevalence. Reddish colors, indicative of a very high prevalence, are also shown in the southeast of the Scandinavian Peninsula, the Island of Amager (Denmark), southeast of Germany, western and southern Poland, Austria, Czech Republic, and Slovakia (these last 2 countries without studies and therefore without real numerical values).

Brown and orange tones (approximately equivalent to a range of numerical values between 15% and 20%) appear in Iceland, Hungary, large areas of Italy (except the regions of Lombardy, Piedmont, Liguria, and Calabria, which appear in yellow color), Croatia, Bosnia and Herzegovina, Serbia, and Greece, as well as in the province of Adana (southern Turkey). Of note, there are no real numerical values for the Balkan countries that were colored by means of the IDW mapping.

Most of the remaining regions of Europe are stained in yellow and green colors, indicative of an intermediate prevalence of \~10%--15%; the Danish peninsula of Jutland, most of Sweden, Norway, and northern Finland, the Baltic seacoast countries and the Baltic islands of Gotland and Aland, Belorussia, most of the lands of Poland, the western half of Germany, the coastal regions of Western Europe and Great Britain bordering the North Sea and the English Channel, Ireland, Portugal, Spain, the Mediterranean major islands, Slovenia, Ukraine, Romania, Bulgaria, European Russia, Montenegro, Albania, Macedonia, and the Anatolian Peninsula are included in this group. Remarkably, many of these regions were stained by IDW interpolation in the absence of real numerical data.

Blue areas (indicative of the prevalence of around or \<5%) are scarce and isolated; Switzerland, the island of Cyprus, some cities of Spain, such as Vigo, Burgos, Cáceres, and Seville, scattered areas of the Scandinavian peninsula and Finland, and the Erzurum Province of eastern Turkey are among them.

Discussion
==========

Existing data on COPD prevalence are in general insufficient and irregularly distributed in many regions of Europe, in some of which there is a striking scarcity or even an absolute lack of epidemiological information about this important health issue.

To assess the COPD prevalence throughout the European continent and its surrounding islands, an efficient method of proven utility, known as IDW multivariate interpolation (or spatial analysis), which is usually applied to various disciplines concerned with the earth's surface, such as cartography, geography, hydrology, climatology, and agriculture, was used in the present study in order to generate a continuous map of COPD prevalence.

Basically, IDW interpolation uses data points with known values to estimate other values at unknown locations, in order to create a raster surface consisting of an array of cells (pixels) arranged in rows and columns (or a grid) in which each cell contains a value representing some prevalence information, finally covering a whole area. The IDW method is based on the assumption that the attribute value of an unsampled point is the weighted average of known values within the 4 nearest data points. IDW assumes that each measured point has a local influence that diminishes with distance, weighting the points closer to the prediction location greater than those located farther away, which means that weights are inversely related to the distances between the sampled locations and the predicted ones.[@b7-copd-13-057]

The IDW interpolation is a simple and intuitive method, easy to handle and interpret, relatively fast for calculations, and easy to compute, which also has the advantage of allowing to easily renewing the database, with a flexibility of the inclusion of studies newly identified, that are more recent, or with a better study design. Similar flexibility applies to the exclusion of others of less scientific quality to automatically reconstructing new, updated maps. In addition, IDW has a mathematical precision that makes it always exact, but this advantage can be a disadvantage if the actual data were erroneous or inaccurate. Since it works automatically creating new points from others supposedly accurate, it is crucial to introduce reliable data; otherwise the final results will also be inaccurate or erroneous.

For the present study, the numerical data of prevalence rates were obtained with the best available evidence in publicly accessible scientific databases, and only surveys constituted by patients of at least ≥40 years of age and a confirmed diagnosis of COPD with spirometry were selected for the analysis.

Limitations
===========

However, the authors of the present study are aware that the analysis may have some limitations due to a number of confounding factors frequently associated with cross-sectional studies, and sometimes these confounding variables could have led to spurious associations. For example, the sampling approach varied from study to study or even among sites in the same study. In addition, the size of the samples was highly variable, with significant differences between regions, and some of them were not proportional to the general population of the studied region. Remarkably, the lack or scarcity of data in extensive regions of Europe makes the scientific hypotheses from which some conclusions were drawn less reliable.

There are also some (though not statistically significant) differences in the age distribution between regions of Europe and even within the same region of the same country, and since in spirometry-based studies the prevalence of COPD increases with age, the lack of homogeneity in this variable may be the reason for some of the erratic values.

On the other hand, when modeling relative risks or ORs from data obtained from a given population, results may not be applicable to populations with different levels of exposure, as the relations may not be linear across all exposure levels. Regrettably, in our study, there was no proportionality between the number of urban and rural cohorts, and thus, studies performed in populations with high levels of smoking or occupational air pollutants exposure may not be generalizable to those of populations with lower levels of exposure.

Another limitation may be related to the differences in case definitions. The definition based on post-BD FEV~1~/FVC \<0.70 was used in the large majority (80%) of studies, but this still does not address all possible sources of variation in case definition, since this fixed ratio criterion may potentially overdiagnose COPD in the elderly and it may underdiagnose COPD in younger patients. Besides, a number of technical issues could have affected the estimates, such as the quality of the commercial models of the spirometers used, the level of training of the operators, and the process of collection and storage of spirometry measurements.[@b2-copd-13-057]--[@b5-copd-13-057]

Finally, an intrinsic limitation of GIS is that geographic proximity does not take into account borders, which often within Europe mirror a different language or dialect. Common language is a well-established factor for unevenly distributing genes, related to or not to health, and many other social determinants.[@b78-copd-13-057]

Nevertheless, in spite of all these criticisms, it should be emphasized that GIS unquestionably offers a useful new tool in epidemiology, which makes it ever easier to connect spatially referenced physical and social phenomena to population patterns of health, disease, and well-being.

Therefore, in our opinion, the easy-to-interpret and eye-catching impacting results of this technique may contribute to enhancing public health surveillance as well as delineating the prevalence of COPD in Europe and in other countries; to increase the number of doctors who treat this type of patients and the health authorities and national governments' interest in strengthening regulations to address occupational and environmental risk factors, regulate tobacco use, and improve public awareness; to all together increase the rate of diagnoses and to implement the application of preventive and therapeutic measures to avoid potential side effects and unnecessary costs; and to reduce the high global COPD burden in coming years.
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![COPD mean prevalence in Europe.\
**Notes:** In this IDW interpolation map, the COPD prevalence is represented by a red--blue scale. Black spots indicate the places of origin of the data obtained from 62 selected studies. Some black spots are also shown in some nearby countries of North Africa and Middle East for guidance.\
**Abbreviation:** IDW, inverse distance weighting.](copd-13-057Fig1){#f1-copd-13-057}

![COPD mean prevalence in Europe.\
**Note:** The IDW interpolation map shows the prevalence values of COPD at the points of origin of the patients, both in Europe and in some neighboring countries in North Africa and the Middle East.\
**Abbreviation:** IDW, inverse distance weighting.](copd-13-057Fig2){#f2-copd-13-057}

![COPD mean prevalence in Europe.\
**Notes:** In this IDW interpolation map, spots and numerical values have been removed to allow a clearer view of the colors with which the different regions appear colored. Although there is not an exact equivalence between the qualitative data provided by the color scale and the numerical values obtained from published studies, there is an approximate correlation between them, which allows interpreting findings of the mapping with reasonable certainty.\
**Abbreviation:** IDW, inverse distance weighting.](copd-13-057Fig3){#f3-copd-13-057}

###### 

Mean prevalence of COPD in 21 studies from 5 Northern Europe countries

  Country   Source of samples     Setting   Age (years)   Diagnosis criteria   COPD prevalence (%)   Study
  --------- --------------------- --------- ------------- -------------------- --------------------- -----------------------------------------
  Denmark   Copenhagen            Urban     63            GOLD                 17                    Fabricius et al[@b11-copd-13-057]
  Denmark   Copenhagen            Urban     50            GOLD                 25                    Maio et al[@b12-copd-13-057]
  Denmark   Aarhus and Aalborg    Mixed     65            GOLD                 12                    Hansen et al[@b13-copd-13-057]
  Finland   Helsinki              Urban     49            GOLD/LLN             6                     Kainu et al[@b14-copd-13-057]
  Finland   Lahti                 Rural     48            GOLD                 9                     Jyrki-Tapani et al[@b15-copd-13-057]
  Finland   Lieto                 Rural     73            FEV~1~/FVC ≤65%      8                     Isoaho et al[@b16-copd-13-057]
  Finland   Ylöjärvi              Mixed     55            GOLD                 5                     Kanervisto et al[@b17-copd-13-057]
  Iceland   Reykjavik             Urban     57            GOLD                 18                    Benediktsdóttir et al[@b18-copd-13-057]
  Norway    Hordaland county      Mixed     55            GOLD                 9                     Waatevik et al[@b19-copd-13-057]
  Norway    Bergen municipality   Mixed     61            GOLD                 9                     Hvidsten et al[@b20-copd-13-057]
  Norway    Bergen                Urban     58            GOLD                 19                    Buist et al[@b21-copd-13-057]
  Norway    Hordaland county      Mixed     42            GOLD                 5                     Bakke et al[@b22-copd-13-057]
  Norway    Bergen municipality   Mixed     46            GOLD                 5                     Johannessen et al[@b23-copd-13-057]
  Sweden    Uppsala               Urban     59            LLN                  10                    Danielsson et al[@b24-copd-13-057]
  Sweden    Lulea                 Rural     61            GOLD                 14                    Lindberg et al[@b25-copd-13-057]
  Sweden    Lulea                 Rural     49            GOLD                 14                    Lindberg et al[@b26-copd-13-057]
  Sweden    Norrbotten county     Rural     61            GOLD                 11                    Lindberg et al[@b26-copd-13-057]
  Sweden    Northern Sweden       Rural     50            BTS                  10                    Lindström et al[@b27-copd-13-057]
  Sweden    Stockholm             Urban     53            GOLD                 20                    Maio et al[@b12-copd-13-057]
  Sweden    Värmland county       Rural     45            BTS                  2                     Hasselgren et al[@b28-copd-13-057]
  Sweden    Örebro                Mixed     49            ATS                  11                    Larsson[@b29-copd-13-057]

**Note:** The numerical values of age and prevalence have been rounded.

**Abbreviations:** ATS, American Thoracic Society; BTS, British Thoracic Society; GOLD, Global Initiative for Chronic Obstructive Lung Disease; LLN, lower limit of normal.

###### 

Mean prevalence of COPD in 11 studies from 3 Western Europe countries

  Country           Source of samples                         Setting   Age (years)   Diagnosis criteria   COPD prevalence (%)   Study
  ----------------- ----------------------------------------- --------- ------------- -------------------- --------------------- ----------------------------------------
  France            Paris                                     Urban     63            GOLD                 7                     Roche et al[@b30-copd-13-057]
  the Netherlands   Maastricht                                Urban     59            GOLD/LLN             19                    Vanfleteren et al[@b31-copd-13-057]
  the Netherlands   Rotterdam                                 Urban     69            GOLD                 12                    van Durme et al[@b32-copd-13-057]
  the Netherlands   General population of the whole country   Mixed     58            GOLD                 4                     Afonso et al[@b33-copd-13-057]
  UK                Birmingham                                Mixed     58            GOLD                 9                     Jordan et al[@b34-copd-13-057]
  UK                Ashington                                 Urban     59            GOLD                 25                    Melville et al[@b35-copd-13-057]
  UK                Greater Belfast area                      Mixed     55            ATS                  7                     Murtagh et al[@b36-copd-13-057]
  UK                Glasgow                                   Urban     51            GOLD                 24                    Maio et al[@b12-copd-13-057]
  UK                Barton-upon-Humber                        Mixed     68            GOLD                 10                    Dickinson et al[@b37-copd-13-057]
  UK                Manchester                                Mixed     64            GOLD                 26                    Renwick and Connolly[@b38-copd-13-057]
  UK                General population of the whole country   Mixed     56            GOLD                 13                    Shahab et al[@b39-copd-13-057]

**Note:** The numerical values of age and prevalence have been rounded.

**Abbreviations:** ATS, American Thoracic Society; GOLD, Global Initiative for Chronic Obstructive Lung Disease; LLN, lower limit of normal.

###### 

Mean prevalence of COPD in 14 studies from 5 Central Europe countries

  Country       Source of samples                         Setting   Age (years)   Diagnosis criteria   COPD prevalence (%)   Study
  ------------- ----------------------------------------- --------- ------------- -------------------- --------------------- ------------------------------------------------
  Austria       Salzburg                                  Mixed     58            GOLD                 17                    Weiss et al[@b40-copd-13-057]
  Austria       Salzburg                                  Urban     59            GOLD                 26                    Schirnhofer et al[@b41-copd-13-057]
  Austria       Vienna                                    Urban     56            GOLD                 20                    Maio et al[@b12-copd-13-057]
  Germany       Hannover                                  Mixed     58            GOLD                 13                    Geldmacher et al[@b42-copd-13-057]
  Germany       Dusseldorf                                Urban     59            GOLD                 9                     Gingter et al[@b43-copd-13-057]
  Germany       Munich                                    Urban     59            GOLD                 21                    Maio et al[@b12-copd-13-057]
  Germany       Berlin                                    Urban     41            GOLD                 16                    Maio et al[@b12-copd-13-057]
  Poland        Warsaw                                    Mixed     57            LLN                  9                     Bednarek et al[@b44-copd-13-057]
  Poland        Malopolska province                       Mixed     56            GOLD                 22                    Nizankowska-Mogilnicka et al[@b45-copd-13-057]
  Poland        Warsaw                                    Urban     49            GOLD                 11                    Plywaczewski et al[@b46-copd-13-057]
  Poland        Lublin region                             Rural     50            GOLD                 11                    Paprzycki et al[@b47-copd-13-057]
  Poland        Bytom                                     Mixed     59            GOLD                 6                     Siatkowska et al[@b48-copd-13-057]
  Slovenia      Sezana (Carso)                            Urban     56            GOLD                 10                    Grzetic-Romcevic et al[@b49-copd-13-057]
  Switzerland   General population of the whole country   Mixed     54            GOLD                 5                     Bridevaux et al[@b50-copd-13-057]

**Note:** The numerical values of age and prevalence have been rounded.

**Abbreviations:** GOLD, Global Initiative for Chronic Obstructive Lung Disease; LLN, lower limit of normal.

###### 

Mean prevalence of COPD in 15 studies from 6 Southern Europe countries

  Country    Source of samples                           Setting   Age (years)   Diagnosis criteria   COPD prevalence (%)   Study
  ---------- ------------------------------------------- --------- ------------- -------------------- --------------------- ---------------------------------------
  Portugal   Lisbon                                      Urban     63            GOLD                 14                    Bárbara et al[@b51-copd-13-057]
  Portugal   General population of the whole country     Mixed     56            GOLD                 9                     Cardoso et al[@b52-copd-13-057]
  Portugal   Porto                                       Urban     58            GOLD                 11                    Mascarenhas et al[@b53-copd-13-057]
  Spain      Multicenter study on 11 cities              Mixed     57            GOLD                 10                    Miravitlles et al[@b54-copd-13-057]
  Spain      Multicenter study on 7 geographical areas   Mixed     54            ERS                  9                     Peña et al[@b55-copd-13-057]
  Spain      Canary Islands                              Urban     55            GOLD                 7                     Cabrera López et al[@b56-copd-13-057]
  Italy      Po Delta area                               Rural     57            GOLD                 23                    Viegi et al[@b57-copd-13-057]
  Italy      Verona                                      Mixed     56            GOLD/LLN             12                    Guerriero et al[@b64-copd-13-057]
  Greece     Exochi, Thessaloniki                        Mixed     52            GOLD                 6                     Sichletidis et al[@b58-copd-13-057]
  Greece     Thessaly region                             Rural     54            GOLD                 18                    Minas et al[@b59-copd-13-057]
  Cyprus     General population of the whole island      Mixed     54            GOLD                 5                     Zachariades et al[@b60-copd-13-057]
  Turkey     Kocaeli city                                Urban     56            GOLD                 13                    Arslan et al[@b61-copd-13-057]
  Turkey     Erzurum                                     Rural     55            GOLD                 5                     Erdogan et al[@b62-copd-13-057]
  Turkey     Malatya region                              Mixed     47            ATS/ERS              7                     Gunen et al[@b63-copd-13-057]
  Turkey     Adana                                       Mixed     54            GOLD                 19                    Buist et al[@b21-copd-13-057]

**Note:** The numerical values of age and prevalence have been rounded.

**Abbreviations:** ATS, American Thoracic Society; ERS, European Respiratory Society; GOLD, Global Initiative for Chronic Obstructive Lung Disease; LLN, lower limit of normal.

###### 

Ages of selected samples, descriptive statistics

  Region            Number of studies   Mean (years)   SD    95% CI (lower limit)   95% CI (upper limit)   Minimum   Maximum
  ----------------- ------------------- -------------- ----- ---------------------- ---------------------- --------- ---------
  Northern Europe   21                  54.8           7.7   51.3                   58.3                   42.0      73.0
  Western Europe    11                  60.3           5.6   56.5                   64.0                   50.9      69.5
  Central Europe    14                  55.0           5.2   52.0                   58.1                   40.1      59.5
  Southern Europe   16                  55.2           3.2   53.5                   56.9                   47.5      62.8
  Global            62                  55.9           6.1   54.4                   57.5                   40.8      73.0

**Note:** Interregions: *p*=0.071, no significant differences (ANOVA).

**Abbreviation:** ANOVA, analysis of variance.

###### 

COPD prevalence in Europe, descriptive statistics

  Region            Number of studies   Mean prevalence (%)   SD    95% CI (lower limit)   95% CI (upper limit)   Minimum   Maximum
  ----------------- ------------------- --------------------- ----- ---------------------- ---------------------- --------- ---------
  Northern Europe   21                  11.5                  5.9   8.8                    14.1                   2.1       25.4
  Western Europe    11                  14.2                  8.0   8.8                    19.6                   3.9       26.4
  Central Europe    14                  14.1                  6.5   10.4                   17.9                   5.0       26.1
  Southern Europe   16                  10.8                  5.6   7.8                    13.8                   4.9       23.4
  Global            62                  12.4                  6.2   10.8                   14.0                   2.1       26.4

**Note:** Interregions: *p*=0.3460, no significant differences (ANOVA).

**Abbreviation:** ANOVA, analysis of variance.
